Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Novartis AG | 2.02% | $56.55M | CHF198.85B | 12.02% | 80 Outperform | |
| ASML Holding NV | 1.78% | $49.61M | €345.09B | 37.21% | 76 Outperform | |
| Nestlé SA | 1.07% | $30.01M | CHF201.76B | 14.02% | 71 Outperform | |
| Roche Holding AG | 1.04% | $29.17M | CHF246.07B | 33.03% | 73 Outperform | |
| Royal Bank Of Canada | 1.02% | $28.49M | $217.15B | 22.61% | 75 Outperform | |
| AstraZeneca | 0.99% | $27.73M | £216.63B | 31.68% | 78 Outperform | |
| Loblaw Companies | 0.98% | $27.31M | $52.37B | 36.50% | 80 Outperform | |
| SAP SE | 0.87% | $24.44M | €243.40B | -7.27% | 66 Neutral | |
| ABB Ltd | 0.86% | $24.12M | kr1.24T | 15.70% | 78 Outperform | |
| ― | 0.82% | $22.84M | ― | ― | ― |